Zealand Pharma (ZEAL.CO)

Nasdaq Copenhagen · Pharmaceutical industry · Financial statements, TTM figures and earnings dates

In fiscal year 2025 (ended December 31, 2025), Zealand Pharma reported revenue of DKK 9.21B and net income of DKK 6.46B. Annual financial statements are available for fiscal years 2022 to 2025, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

DKK	FY2025 2025-12-31	FY2024 2024-12-31	FY2023 2023-12-31	FY2022 2022-12-31
Income statement
Revenue	DKK 9.21B	DKK 62.7M	DKK 342.8M	DKK 104.0M
Gross profit	DKK 9.21B	DKK 54.8M	DKK 323.6M	DKK 104.0M
Operating income	DKK 6.96B	−DKK 1.27B	−DKK 572.2M	−DKK 837.2M
Net income	DKK 6.46B	−DKK 1.08B	−DKK 703.7M	−DKK 1.20B
Diluted EPS	DKK 90.22	−DKK 16.24	−DKK 12.44	−DKK 26.02
Cash flow
Operating cash flow	DKK 6.53B	−DKK 930.8M	−DKK 425.7M	−DKK 942.3M
Capital expenditure	DKK 33.4M	DKK 10.1M	DKK 11.2M	DKK 11.7M
Free cash flow	DKK 6.50B	−DKK 940.9M	−DKK 436.9M	−DKK 954.0M
Balance sheet
Cash and equivalents	DKK 4.58B	DKK 726.0M	DKK 668.6M	DKK 1.07B
Total assets	DKK 15.95B	DKK 9.51B	DKK 1.98B	DKK 1.54B
Total liabilities	DKK 1.12B	DKK 888.9M	DKK 387.2M	DKK 723.9M
Total debt	DKK 302.9M	DKK 285.3M	DKK 0	DKK 401.3M
Shareholders' equity	DKK 14.83B	DKK 8.62B	DKK 1.59B	DKK 815.9M

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in DKK as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full ZEAL.CO page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open ZEAL.CO financials →